Jan Verstreken - Net Worth and Insider Trading

Jan Verstreken Net Worth

The estimated net worth of Jan Verstreken is at least $5 Million dollars as of 2024-04-27. Jan Verstreken is the Group President, International of Hologic Inc and owns about 64,191 shares of Hologic Inc (HOLX) stock worth over $5 Million. Details can be seen in Jan Verstreken's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jan Verstreken has not made any transactions after 2022-05-17 and currently still holds the listed stock(s).

Transaction Summary of Jan Verstreken

To

Jan Verstreken Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jan Verstreken owns 1 companies in total, including Hologic Inc (HOLX) .

Click here to see the complete history of Jan Verstreken’s form 4 insider trades.

Insider Ownership Summary of Jan Verstreken

Ticker Comapny Transaction Date Type of Owner
HOLX Hologic Inc 2022-05-17 Group President & International

Jan Verstreken Latest Holdings Summary

Jan Verstreken currently owns a total of 1 stock. Jan Verstreken owns 64,191 shares of Hologic Inc (HOLX) as of May 17, 2022, with a value of $5 Million.

Latest Holdings of Jan Verstreken

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOLX Hologic Inc 2022-05-17 64,191 75.98 4,877,232

Holding Weightings of Jan Verstreken


Jan Verstreken Form 4 Trading Tracker

According to the SEC Form 4 filings, Jan Verstreken has made a total of 1 transactions in Hologic Inc (HOLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Hologic Inc is the sale of 6,500 shares on May 17, 2022, which brought Jan Verstreken around $512,200.

Insider Trading History of Jan Verstreken

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jan Verstreken Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jan Verstreken Ownership Network

Ownership Network List of Jan Verstreken

No Data

Ownership Network Relation of Jan Verstreken


Jan Verstreken Owned Company Details

What does Hologic Inc do?

Who are the key executives at Hologic Inc?

Jan Verstreken is the Group President & International of Hologic Inc. Other key executives at Hologic Inc include Corp. VP & Finance & Acconting Karleen Marie Oberton , director & President and CEO Stephen P Macmillan , and Div. President & GYN Surgical Essex D Mitchell .

Hologic Inc (HOLX) Insider Trades Summary

Over the past 18 months, Jan Verstreken made no insider transaction in Hologic Inc (HOLX). Other recent insider transactions involving Hologic Inc (HOLX) include a net sale of 219,633 shares made by Stephen P Macmillan , a net sale of 36,441 shares made by Scott T Garrett , and a net sale of 29,485 shares made by Karleen Marie Oberton .

In summary, during the past 3 months, insiders sold 41,885 shares of Hologic Inc (HOLX) in total and bought 0 shares, with a net sale of 41,885 shares. During the past 18 months, 378,767 shares of Hologic Inc (HOLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 378,767 shares.

Hologic Inc (HOLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Hologic Inc Insider Transactions

No Available Data

Jan Verstreken Mailing Address

Above is the net worth, insider trading, and ownership report for Jan Verstreken. You might contact Jan Verstreken via mailing address: 250 Campus Drive, Marlborough Ma 01752.

Discussions on Jan Verstreken

No discussions yet.